Canon is considering acquisitions in medical devices and semiconductor equipment as part of its new five-year plan.

The company, known for cameras, printers, and lithography machines, plans to invest ¥3 trillion (US$19 billion) into current operations and may set aside up to ¥2 trillion (US$12.6 billion) more for potential deals.

It also lowered its dividend payout target to about 40%, down from 50%, while expecting shareholder returns to exceed ¥1 trillion (US$ 6.3 billion) over five years and maintaining flexibility on stock buybacks.

Shares fell 0.9% after the announcement.

Canon faces challenges in its traditional camera market and capital-heavy chip tool sector, with clients such as Taiwan Semiconductor Manufacturing Co.

🔗 Source: Bloomberg